234 related articles for article (PubMed ID: 8993829)
1. Receptor tyrosine kinase signaling in vascular development.
Merenmies J; Parada LF; Henkemeyer M
Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
[No Abstract] [Full Text] [Related]
2. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
3. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
4. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
5. [Role of the ETS transcription factors in the control of endothelial-specific gene expression and in angiogenesis].
Lelièvre E; Lionneton F; Soncin F
Bull Cancer; 2001 Feb; 88(2):137-42. PubMed ID: 11257588
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
[TBL] [Abstract][Full Text] [Related]
7. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
Fong GH; Rossant J; Gertsenstein M; Breitman ML
Nature; 1995 Jul; 376(6535):66-70. PubMed ID: 7596436
[TBL] [Abstract][Full Text] [Related]
8. Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
[No Abstract] [Full Text] [Related]
9. Angiogenesis in embryos and ischemic diseases.
Breier G; Damert A; Plate KH; Risau W
Thromb Haemost; 1997 Jul; 78(1):678-83. PubMed ID: 9198238
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex.
Tsiamis AC; Morris PN; Marron MB; Brindle NP
Microvasc Res; 2002 Mar; 63(2):149-58. PubMed ID: 11866538
[TBL] [Abstract][Full Text] [Related]
11. [Growth factors binding heparin: FGF and VEGF. Physiological and physiopathological importance, therapeutic implications in diabetic retinopathy].
Favard C; Patry V; Prats H; Plouet J; Bayard F
Journ Annu Diabetol Hotel Dieu; 1995; ():39-51. PubMed ID: 7602891
[No Abstract] [Full Text] [Related]
12. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
[TBL] [Abstract][Full Text] [Related]
13. VEGF receptor signal transduction.
Matsumoto T; Claesson-Welsh L
Sci STKE; 2001 Dec; 2001(112):re21. PubMed ID: 11741095
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor: environmental controls and effects in angiogenesis.
Hlatky L; Hahnfeldt P; Tsionou C; Coleman CN
Br J Cancer Suppl; 1996 Jul; 27():S151-6. PubMed ID: 8763869
[No Abstract] [Full Text] [Related]
16. Cartilage to bone--angiogenesis leads the way.
Harper J; Klagsbrun M
Nat Med; 1999 Jun; 5(6):617-8. PubMed ID: 10371495
[No Abstract] [Full Text] [Related]
17. Growth factor signaling pathways in vascular development.
Tallquist MD; Soriano P; Klinghoffer RA
Oncogene; 1999 Dec; 18(55):7917-32. PubMed ID: 10630644
[TBL] [Abstract][Full Text] [Related]
18. VEGF-FLT1 receptor system: a new ligand-receptor system involved in normal and tumor angiogenesis.
Birnbaum D
Jpn J Cancer Res; 1995 Jul; 86(7):inside cover. PubMed ID: 7559075
[No Abstract] [Full Text] [Related]
19. [Anti-angiogenic reagents].
Shibuya M
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1182-7. PubMed ID: 10771693
[No Abstract] [Full Text] [Related]
20. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]